95209-83-9

Basic information

• Product Name: 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI)
• Synonyms: 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI);Albb-005387;(2-oxo-1(2H)-pyrimidinyl)acetic acid(SALTDATA: FREE);(2-oxo-1(2H)-pyrimidinyl)acetic acid
• CAS NO: 95209-83-9
• Molecular Formula: C₆H₆N₂O₃
• Molecular Weight: 154.124
• Product Categories: GLYCINESCAFFOLD
• Mol File: 95209-83-9.mol

Chemical Properties

• Boiling Point: 354.8°C at 760 mmHg
• Flash Point: 168.4°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 5.46E-06mmHg at 25°C
• Refractive Index: 1.606
• CAS DataBase Reference: 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI)(95209-83-9)
• EPA Substance Registry System: 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI)(95209-83-9)

Safety Data

• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 95209-83-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1(2H)-Pyrimidineaceticacid,2-oxo-(9CI) is used as a building block in the synthesis of various pharmaceutical products. Its unique chemical structure and potential biological activity contribute to the development of new drugs and therapeutic agents.
Used in Drug Discovery and Development:
1(2H)-Pyrimidineaceticacid,2-oxo-(9CI) is utilized in the field of drug discovery and development due to its potential biological properties. Researchers are studying its effects and applications to better understand its role in creating novel pharmaceutical compounds.
However, it is important to note that further research is needed to fully understand the potential applications and effects of 1(2H)-Pyrimidineaceticacid,2-oxo-(9CI) in various industries.

InChI:InChI=1/C6H6N2O3/c9-5(10)4-8-3-1-2-7-6(8)11/h1-3H,4H2,(H,9,10)

Upstream product

• 94495-98-4 Ethyl (1,2-dihydro-2-oxo-1-pyrimidinyl)acetate 
• 38353-09-2 2-hydroxypyrimidine hydrochloride 
• 79-11-8 chloroacetic acid 
• 557-01-7 Pyrimidin-2(1H)-one 

Downstream Products

• 1345888-19-8 C₃₂H₃₀N₄O₆ 

Relevant articles and documents

Nitrogen heterocyclic ring group substituted amide derivative and application thereof

The invention discloses a nitrogen heterocyclic ring group substituted amide derivative and application thereof, particularly relates to a novel nitrogen heterocyclic ring group substituted amide derivative and a drug composition comprising the compound, and further relates to methods for preparing the compound and the drug composition, and application of the compound and the drug composition to preparation of drugs for treating diseases or symptoms, particularly overactive bladder, excited and mediated by beta 3-adrenergic receptors. The compound and the drug composition can be used for activating the beta 3-adrenergic receptors.

HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS

The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

Linked peptide nucleic acids

Novel peptide nucleic acids and novel linked peptide nucleic acids, form triple stranded structures with nucleic acids. The peptide nucleic acids include ligands such as naturally occurring nucleobases attached to the peptide backbone through a suitable linker. Other nucleobases including C-pyrimidines and iso-pyrimidines can be used as the ligands in Hoogsteen strands to increase binding affinity. Two peptide nucleic acid strands are joined together with a linker to form a bis-peptide nucleic acid. The individual strands of the peptide nucleic acids in the bis compounds can be oriented either parallel or antiparallel to each other.